Studies

CellWell record HH-343593

Cardiovascular event rate modifies response to pharmacologic LDL-C lowering in primary prevention: implications of a systematic review and meta-analysis for clinical practice

Karungi I; Stevens CAT; Brandts J; Ray KK

American journal of preventive cardiology ยท 2026

In plain language

Lower-risk primary prevention patients gained greater relative benefits per mmol/L LDL-C reduction than higher-risk patients, requiring smaller absolute reductions.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-343593

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.